VC funding in Europe falls short at early-stage investment hurdles
While Europe is often lauded for its robust science, late-stage investment has historically been challenging to secure. Yet speakers at…
News
Pentagon drops WuXi AppTec from Chinese military company list
China’s burgeoning novel medicines success presents opportunity for Europe
Delix Therapeutics raises $100m for zalsupindole development
Charles River agrees $470m deal for Frontage assets
Network Bio partners with Duke University on AI disease models
Bio-Thera gains Chinese approval for spondylitis and rheumatoid arthritis drug
FDA expands J&J’s Rybrevant Faspro label with head and neck cancer approval
